US 8,137,714 B2Granted

Compositions comprising docynia delavajy extract and/or Elaeagnus lancelotus extract

AssigneeMary Kay Inc.

InventorsTiffany Florence, Michelle Hines

Life of this patent

Estimating the term…

Abstract

Disclosed are compositions that include Docynia delavajy extract, Elaeagnus lanceolatus extract, or a combination of such extracts.

Claims7

Dependent claims

A method of treating skin comprising topically applying a composition comprising Docynia delavajy leaf and stem extract and Elaeagnus lanceolatus leaf and stem extract to skin in need thereof, wherein the composition inhibits TNF-α and MMP-1 activity in the skin.

Dependencies are inferred from the claim text.

Facts

Application: 13/055,876Filed 27 Jul 2009 · us provisional application
Priority: 25 Jul 2008
Published: US 2011/0189322 A14 Aug 2011
Granted: 20 Mar 2012
Term ends: Not estimatedThe source records don’t support an estimate.

Classification16 codes

A61K 8/9789
Angiosperms [Magnoliophyta]: magnoliopsida [dicotyledons]
A61K 8/064
Emulsions: water-in-oil emulsions, e.g. Water-in-silicone emulsions
A61K 9/0014
Galenical forms characterised by the site of application: skin, i.e. galenical aspects of topical compositions
A61K 9/08
Medicinal preparations characterised by special physical form: solutions

Family

Application61/083,782Us provisional application · filed 25 Jul 2008
Application61/083,797Us provisional application · filed 25 Jul 2008
US 2011/0189322 A1Pre-grant publication · published 4 Aug 2011
US 8,137,714 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results